.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Kidney Cancer
. Ed(S): Figlin, Robert A. (University Of California, Los Angeles, Usa)
€ 193.81
FREE Delivery in Ireland
Description for Kidney Cancer
Paperback. Editor(s): Figlin, Robert A. (University of California, Los Angeles, USA). Series: Cancer Treatment and Research. Num Pages: 246 pages, biography. BIC Classification: MJCL; MNK. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 14. Weight in Grams: 403.
Kidney cancer is a heterogenous disease. This book covers:
Kidney cancer is a heterogenous disease. This book covers:
-new surgical approaches which are becoming the standard, i.e., nephon sparing, laporascopic, minimally invasive techniques;
-new staging and prognostic capabilities;
-evolving therapeutic options include, cell based vaccine, gene and antibody therapy;
-molecular genetics allow for a better understanding of the various types of kidney cancer.
Product Details
Format
Paperback
Publication date
2012
Publisher
Springer-Verlag New York Inc. United States
Number of pages
246
Condition
New
Series
Cancer Treatment and Research
Number of Pages
246
Place of Publication
New York, NY, United States
ISBN
9781461350835
SKU
V9781461350835
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
About . Ed(S): Figlin, Robert A. (University Of California, Los Angeles, Usa)
Robert A. Figlin, Professor of Medicine, Urology, Departments of Medicine and Urology, Division of Hematology/Oncology, University of California, Los Angeles School of Medicine, USA, holds the Henry Alvin and Carrie L. Meinhardt Chair in Urologic Oncology. He serves as Medical Director of the Thoracic and Genitourinary Oncology Program. He is a Senior Clinical Investigator in areas of genitourinary and thoracic ... Read more
Reviews for Kidney Cancer
"This text provides a comprehensive overview of kidney cancer. Investigative leaders in the field discuss the genetic, biologic and clinical manifestations of the disease. Modern therapy is reviewed with commentary on future alternatives and novel compounds." (Steven T. Rosen, M.D., Series Editor)